Adverse events related to treatment with imatinib
| Adverse event5-150 . | All patients (n = 235) . | |
|---|---|---|
| All grades n (%) . | Grade 3 or 4 n (%) . | |
| Nausea | 153 (65) | 8 (3) |
| Edema | 150 (64) | 6 (3) |
| Vomiting | 114 (49) | 3 (1) |
| Diarrhea | 88 (37) | 1 (0.4) |
| Muscle cramps | 75 (32) | 1 (0.4) |
| Dermatitis | 52 (22) | 3 (1) |
| Dyspepsia | 38 (16) | 0 |
| Fatigue | 25 (11) | 6 (3) |
| Myalgia | 30 (13) | 3 (1) |
| Headache | 30 (13) | 3 (1) |
| Arthralgia | 29 (12) | 7 (3) |
| Hemorrhage | 29 (12) | 4 (2) |
| Weight increase/fluid retention | 27 (11) | 3 (1) |
| Pain in limb | 27 (11) | 2 (0.9) |
| Abdominal pain, upper | 24 (10) | 1 (0.4) |
| Bone pain | 20 (9) | 1 (0.4) |
| Pruritus | 20 (9) | 1 (0.4) |
| Anorexia | 18 (8) | 3 (1) |
| Abdominal pain | 16 (7) | 1 (0.4) |
| Adverse event5-150 . | All patients (n = 235) . | |
|---|---|---|
| All grades n (%) . | Grade 3 or 4 n (%) . | |
| Nausea | 153 (65) | 8 (3) |
| Edema | 150 (64) | 6 (3) |
| Vomiting | 114 (49) | 3 (1) |
| Diarrhea | 88 (37) | 1 (0.4) |
| Muscle cramps | 75 (32) | 1 (0.4) |
| Dermatitis | 52 (22) | 3 (1) |
| Dyspepsia | 38 (16) | 0 |
| Fatigue | 25 (11) | 6 (3) |
| Myalgia | 30 (13) | 3 (1) |
| Headache | 30 (13) | 3 (1) |
| Arthralgia | 29 (12) | 7 (3) |
| Hemorrhage | 29 (12) | 4 (2) |
| Weight increase/fluid retention | 27 (11) | 3 (1) |
| Pain in limb | 27 (11) | 2 (0.9) |
| Abdominal pain, upper | 24 (10) | 1 (0.4) |
| Bone pain | 20 (9) | 1 (0.4) |
| Pruritus | 20 (9) | 1 (0.4) |
| Anorexia | 18 (8) | 3 (1) |
| Abdominal pain | 16 (7) | 1 (0.4) |
Events reported in at least 5% of patients.